Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lotte van der Wagen"'
Autor:
Moniek de Witte, Laura G. M. Daenen, Lotte van der Wagen, Anna van Rhenen, Reiner Raymakers, Kasper Westinga, Jürgen Kuball
Publikováno v:
HemaSphere, Vol 5, Iss 6, p e580 (2021)
Various allogeneic (allo) stem cell transplantation platforms have been developed over the last 2 decades. In this review we focus on the impact of in vivo and ex vivo graft manipulation on immune reconstitution and clinical outcome. Strategies inclu
Externí odkaz:
https://doaj.org/article/3f36b76bc11f454ca155290f0fa242a7
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Cytomegalovirus (CMV) infection can cause significant complications after transplantation, but recent emerging data suggest that CMV may paradoxically also exert beneficial effects in two specific allogeneic transplant settings. These potential benef
Externí odkaz:
https://doaj.org/article/e5affe66198a4905a089533eb5301503
Autor:
Moniek de Witte, Jojanneke Scheepstra, Naomi Weertman, Annet Daudeij, Lotte van der Wagen, Rimke Oostvogels, Colin de Haar, Henk-Jan Prins, Willem Dohmen, Carly Bartels-Wilmer, Inez Johanna, Zsolt Sebestyen, Jurgen Kuball, Trudy Straetemans
Publikováno v:
Blood. 140:12737-12739
Autor:
Klaartje Nijssen, Kasper Westinga, Anniek Stuut, Anke Janssen, Anna van Rhenen, Lotte van der Wagen, Laura G. M. Daenen, Rimke Oostvogels, Moniek A. de Witte, Jürgen Kuball
Publikováno v:
Bone Marrow Transplantation.
Autor:
Anna van Rhenen, Lotte van der Wagen, Jürgen Kuball, Kasper Westinga, Reiner Raymakers, Moniek de Witte, Laura G.M. Daenen
Publikováno v:
HemaSphere, Vol 5, Iss 6, p e580 (2021)
HemaSphere
HemaSphere
Various allogeneic (allo) stem cell transplantation platforms have been developed over the last 2 decades. In this review we focus on the impact of in vivo and ex vivo graft manipulation on immune reconstitution and clinical outcome. Strategies inclu
Autor:
Trudy Straetemans, Froso Karaiskaki, Anna van Rhenen, Constantijn J.M. Halkes, Lotte van der Wagen, Monique C. Minnema, Anke Janssen, Klaartje Nijssen, Luuk Swanenberg, Jürgen Kuball, Reinier Raymakers, Moniek A. de Witte, Eefke Petersen, Rick Admiraal, Jaap-Jan Boelens, Kasper Westinga
Publikováno v:
Blood Adv
Blood Advances, 5(1), 240-249. AMER SOC HEMATOLOGY
Blood Advances, 5(1), 240-249. AMER SOC HEMATOLOGY
We conducted a multicenter prospective single-arm phase 1/2 study that assesses the outcome of αβ T-cell depleted allogeneic hematopoietic stem cell transplantation (allo-HSCT) of peripheral blood derived stem cells from matched related, or unrelat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ec74445db1f4332a6b4485b2127edfd
https://hdl.handle.net/1887/3279607
https://hdl.handle.net/1887/3279607
Autor:
Lotte van der Wagen, Julia Drylewicz, Mariona Baliu-Piqué, José Borghans, Sigrid A. Otto, Vera van Hoeven, Jürgen Kuball, Rob J. de Boer, Kiki Tesselaar, Menno C. van Zelm, Anke Janssen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cc462735fd4a5e38ab7fc32b671706f
https://doi.org/10.7554/elife.59775.sa2
https://doi.org/10.7554/elife.59775.sa2
Autor:
Lotte van der Wagen, Vera van Hoeven, Kiki Tesselaar, Menno C. van Zelm, Anke Janssen, Mariona Baliu-Piqué, Sigrid A. Otto, José A. M. Borghans, Julia Drylewicz, Rob J. de Boer, Jürgen Kuball
Lymphocyte numbers need to be quite tightly regulated. It is generally assumed that lymphocyte production and survival rates increase homeostatically when lymphocyte numbers decrease. This widely-accepted concept is largely based on experiments in mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c86b1f15a7d4a44999a0c287545bac10
https://doi.org/10.1101/2020.04.24.20078295
https://doi.org/10.1101/2020.04.24.20078295
Autor:
Colin de Haar, Kasper Westinga, Mette D. Hazenberg, Caroline A. Lindemans, Sanne van Dooremalen, Rick Admiraal, Lotte van der Wagen, Jürgen Kuball, Magdalena J. Lorenowicz, Anke Janssen, Jaap Jan Boelens, Walter J.F.M. van der Velden, Febilla Fernando, Nagesha Appukudige, Rien van Marwijk Kooy, Annoek E.C. Broers, Jeroen Janssen, Gerwin Huls, Alberto Miranda-Bedate
Publikováno v:
Bone Marrow Transplantation, 55, 2188-2192
Bone Marrow Transplantation, 55(11), 2188-2192. Nature Publishing Group
Bone marrow transplantation, 55(11), 2188-2192. Nature Publishing Group
van der Wagen, L E, Miranda-Bedate, A, Janssen, A, Fernando, F, Appukudige, N, van Dooremalen, S, Westinga, K, Admiraal, R, Lorenowicz, M J, Huls, G, Janssen, J J W M, Broers, A E C, van der Velden, W J F M, van Marwijk Kooy, R, Hazenberg, M D, de Haar, C, Lindemans, C, Jan Boelens, J & Kuball, J 2020, ' Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile ', Bone Marrow Transplantation, vol. 55, no. 11, pp. 2188-2192 . https://doi.org/10.1038/s41409-020-0910-9
Bone Marrow Transplantation, 55, 11, pp. 2188-2192
Bone Marrow Transplantation, 55(11), 2188-2192. Nature Publishing Group
Bone marrow transplantation, 55(11), 2188-2192. Nature Publishing Group
van der Wagen, L E, Miranda-Bedate, A, Janssen, A, Fernando, F, Appukudige, N, van Dooremalen, S, Westinga, K, Admiraal, R, Lorenowicz, M J, Huls, G, Janssen, J J W M, Broers, A E C, van der Velden, W J F M, van Marwijk Kooy, R, Hazenberg, M D, de Haar, C, Lindemans, C, Jan Boelens, J & Kuball, J 2020, ' Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile ', Bone Marrow Transplantation, vol. 55, no. 11, pp. 2188-2192 . https://doi.org/10.1038/s41409-020-0910-9
Bone Marrow Transplantation, 55, 11, pp. 2188-2192
Contains fulltext : 229413.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07b48fc123a55f88a9f68c16049df95b
http://hdl.handle.net/2066/229413
http://hdl.handle.net/2066/229413
Autor:
Lotte van der Wagen, Moniek de Witte, Julie M Janssen, Mar Bellido, Alwin D. R. Huitema, Niels de Jong, Eefke Petersen, Jürgen Kuball, Reinier A P Raijmakers, Jaap Jan Boelens, B. Bär, Ellen Meijer
Publikováno v:
Bone Marrow Transplantation, 54, 7, pp. 1141-1144
Bone Marrow Transplantation, 54(7), 1141-1144. Nature Publishing Group
Bone marrow transplantation, 54(7), 1141-1144. Nature Publishing Group
Bone Marrow Transplantation, 54, 1141-1144
van der Wagen, L, Janssen, J, Raijmakers, R, Petersen, E, de Witte, M, de Jong, N, Bellido, M, Meijer, E, Bär, B, Jan Boelens, J, Huitema, A & Kuball, J R 2019, ' Tyrosine kinase inhibitor levels matter in treating chronic GVHD ', Bone Marrow Transplantation, vol. 54, no. 7, pp. 1141-1144 . https://doi.org/10.1038/s41409-018-0429-5
Bone Marrow Transplantation, 54(7), 1141-1144. Nature Publishing Group
Bone marrow transplantation, 54(7), 1141-1144. Nature Publishing Group
Bone Marrow Transplantation, 54, 1141-1144
van der Wagen, L, Janssen, J, Raijmakers, R, Petersen, E, de Witte, M, de Jong, N, Bellido, M, Meijer, E, Bär, B, Jan Boelens, J, Huitema, A & Kuball, J R 2019, ' Tyrosine kinase inhibitor levels matter in treating chronic GVHD ', Bone Marrow Transplantation, vol. 54, no. 7, pp. 1141-1144 . https://doi.org/10.1038/s41409-018-0429-5
We observed a possible concentration effect relationship for nilotinib on resolution of chronic Graft versus Host disease.These data suggest therapeutic drug monitoring might be useful for patients receiving tyrosine kinase inhibitors for chronic GVH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3e71ed3f45fa08fede13aee05fd0193
https://hdl.handle.net/2066/208391
https://hdl.handle.net/2066/208391